Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
10/3/2025
OncoC4 Raises $50M in Series B to Advance Next-Generation Cancer Thera...
10/3/2025
Baidu-Backed Biotech Start-up Aims to Overtake AlphaFold in China's AI...
10/1/2025
Full-Life Tech Nets $77M to Propel Radiopharma Ambitions
10/1/2025
CSPC Unit Accelerates Hong Kong Listing Amid China's Biotech Rally
10/1/2025
Binhui Biopharma Seeks Hong Kong Listing
9/30/2025
Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff ...
9/30/2025
Haixi Pharma Files for Hong Kong IPO
9/30/2025
China's Biopharma Sector Sees Surge in IPO Activity on HKEX and SSE
9/30/2025
Wuhan Binhui Biopharma Files for Hong Kong IPO
9/29/2025
China Eliminates 30% Import Duty on Indian Drugs Amid Global Trade Shi...
9/29/2025
Avistone's IPO Application on STAR Market Gains Approval
9/29/2025
Phecda Secures Series A+ Financing to Advance Mitochondrial Drug Devel...
9/29/2025
Novatim Strikes Licensing Deal for Dual-Target CAR-T Therapy as China ...
9/29/2025
Santo Thera Secures Angel+ Round to Power Lentiviral Gene Therapy Push
9/26/2025
Genocury Biotech Secures Angel+ Funding to Advance Universal Cell Ther...
9/26/2025
AusperBio Secures $73M Series B to Propel Lead Hepatitis B Program
9/25/2025
Eli Radiopharma Raises Over CNY 100M in Angel+ Financing Round
9/24/2025
Epigenic Secures $60M Series B to Advance Epigenetic Medicines in Chin...
9/24/2025
Hengrui's ADC SHR-A181 Lands $1.1B Licensing Deal with Glenmark
9/23/2025
China Emerges as Global Leader in Cell and Gene Therapy Trials Amid We...
9/23/2025
ZA Biomedical Secures Series A+ Funding
9/23/2025
Affinity Biopharma Reports Major New Funding Round for Tumor-Activated...
9/23/2025
CMS and Generix Join Forces for Innovative Biologics
9/23/2025
MicuRx Plans Private Placement to Raise Up to ¥1B
9/23/2025
GenFleet Soars on HKSE Debut, Raising HK$1.67B in Record IPO
9/23/2025
Hangzhou Sciwind Biosciences Files for HKEX Listing
9/22/2025
AusperBio Secures $63M Series B2 Financing
9/22/2025
YolTech Raises $45M to Fund Its First Phase 3 CRISPR Trial
9/19/2025
GE HealthCare Explores Selling Stake in China Unit Amid Market Pressur...
9/19/2025
Novartis Vows Greater Commitment to China Amid Innovation Surge
Page:
2
/
25
Total number of articles:
735
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit